SlideShare una empresa de Scribd logo
1 de 79
Presenter-Dr Rahul Arya
Vasculitis is a clinicopathologic process 
characterized by inflammation and damage to 
blood vessels, leading to compromise of the 
vascular lumen resulting in ischemia of the 
tissues supplied by the involved vessels.
Inflammatory destruction 
of blood vessels 
• Infiltration of vessel 
wall with inflammatory 
cells 
– Leukocytoclasis 
– Elastic membrane 
disruption 
• Fibrinoid necrosis of 
the vessel wall 
• Ischemia, occlusion, 
thrombosis 
• Aneurysm formation 
• Rupture, hemorrhage
ANCA are antibodies directed against certain 
proteins in cytoplasmic granules of 
neutrophils and monocytes. 
Types-i. 
Cytoplasmic ANCA 
ii. Perinuclear ANCA
Cytoplasmic ANCA 
◦ Stains cytoplasm 
(hence “c”) 
◦ Main target antigen: 
proteinase-3 
◦ Associated with 
wegner’s 
granulomatosis 
(Granulomatosis with 
Polyangitis). 
Perinuclear ANCA 
◦ Stains perinuclear 
(hence “p”) 
◦ Main target antigen: 
myeloperoxidase 
◦ Associated with 
churg strauss and 
microscopic 
polyangitis.
Granulomatous vasculitis of upper and lower 
respiratory tracts with glomerulonephritis. 
Mean age of onset-40 years 
M:F= 1:1. 
Histopathological hallmark-necrotizing 
vasculitis of small arteries and veins with 
granuloma formation.
Lung-multiple, 
bilateral,nodular, 
cavitary infiltrate 
Renal-focal,segmental 
glomerulitis that evolve into 
rapidly progressive 
crescentic glomerulnephritis
Upper airway (95%)-PNS pain, purulent/bloody 
nasal discharge,nasal septal perforation (saddle 
nose). 
Pulmonary (85-90%)-cough, haemoptysis, 
dyspnea, chest discomfort. 
Renal (77%)-proteinuria, hematuria, RBC cast. 
Eye (52%) conjuctivitis, dacrocystitis, episcleritis, 
scleritis , ciliary vessel vasculitis, retroorbital 
mass lesion.
Skin (46%)-papules, vesicles, palpable 
purpura, ulcer or s/c nodules. 
Nervous system (23%)- cranial neuritis, 
mononeuritis multiplex, cerebral vasculitis. 
Cardiac (8%)- pericarditis,coronary vasculitis, 
cardiomyopathy. 
Nonspecific symptoms- malaise, weakness, 
arthralgia and weight loss.
Laboratory finding-ESR is raised, mild anemia, 
leukocytosis, mild hypergammaglobulinemia, 
mildly elevated rheumatoid factor.
Demonstration of necrotizing granulomatous 
vasculitis on tissue biopsy. 
Pulmonary tissue-highest diagnostic yield. 
Renal biopsy-paauci-immune 
glomerulonephritis. 
Antibodies to cANCA-present in 90% pt with 
active disease; without active disease 
sensitivity is 60-70%.
Cyclophosphamide + Glucocorticoid- for induction of 
therapy in severe disease. 
 Prednisolone 1mg/kg/d for 1st month f/b gradual 
tapering on alternate day or daily schedule with 
discontinuation after 6-9 months. 
 Cyclophosphamide 2mg/kg/d orally for 3-6 months. 
Remission maintanence- 
• Methotrexate 0.3 mg/kg single weekly (max 15 mg/week) 
• Azathioprine 2mg/kg/d 
• Mycophenolate mofetil- 1000 mg bd 
Maintanence therapy given for min 2 years.
On t/t with cyclophosphamide 
• marked improvement is seen in >90% patient; 
• complete remission in 75% patient; 
• 5 year patient survival is >80%.
It is a systemic necrotizing vasculitis without 
immune globulin deposition (pauci-immune) that 
affects mainly small vessels. 
Glomerulonephritis and pulmonary capillaritis is 
common. 
No granuloma formation. 
Mean age of onset- 57 years. 
M>F
Mainly involves capillaries,venules along with 
small and medium sized arteries. 
Paucity of immunoglobin deposition. 
Associated with ANCA.
Onset may be gradual- fever, weight loss and 
musculoskelatal pain. 
Glomerulonephritis (79%)-can be rapidly 
progressive leading to renal failure. 
Alveolar haemorrhage (12%)- haemoptysis. 
Mononeuritis multiplex, GI tract and 
cutaneous vasculitis.
Lab Findings- 
ESR- raised 
Anaemia 
Leukocytosis 
Thrombocytosis 
ANCA- present in 
75% 
(antimyeloperoxida 
se antibodies)
Based on histologic evidence of vasculitis or 
pauciimmune glomerulnephritis. 
Sensitivity and specificity of ANCA is not 
established.
Cyclophosphamide with prednisolone. 
5 year survival with t/t is 74%.
Also referred to as allergic angiitis and 
granulomatosis. 
characterized by asthma, peripheral and 
tissue eosinophilia , extravascular granuloma 
formation, and vasculitis of multiple organ 
systems. 
Incidence-uncommon (1-3/million) 
Mean age- 48 years 
M:F- 1.2:1.
Involves small and medium-sized muscular 
arteries, capillaries, veins, and venules. 
characteristic histopathologic feature-granulomatous 
reactions associated with 
infiltration of the tissues with eosinophils. 
Lung involvement is predominant.
Nonspecific-Fever, malaise,anorexia, and 
weight loss. 
Pulmonary finding-M/C manifestation 
Severe asthmatic attacks with pulmonary 
infiltration. 
Mononeuritis multiplex-2nd most common 
manifestation. 
Allergic rhinitis and sinusitis-61% 
Heart disease-14% ;important cause of 
mortality (CHF or Heart attack).
Skin lesions occur in 51% of patients and 
include purpura in addition to cutaneous and 
subcutaneous nodules. 
The renal disease is less common and 
generally less severe.
Purpura 
Subcutaneous Nodules
The characteristic finding-eosinophilia. 
Evidence of inflammation-elevated ESR, 
fibrinogen, or α2-globulins 
48% of patients have circulating ANCA that is 
usually antimyeloperoxidase(pANCA).
Lanham’s criteria (all of the following) 
◦ Asthma 
◦ Peak eosinophilia >1.5 x 109 cells/L 
◦ Systemic vasculitis, two or > extrapulmonary sites 
American College of Rheumatology (4 of the 
following in the setting of vasculitis) 
◦ Asthma 
◦ Peak eosinophilia >10% total WBC 
◦ Peripheral neuropathy attributed to vasculitis 
◦ Transient pulmonary infiltrates 
◦ Paranasal sinus disease 
◦ Biopsy showing blood vessels with extravasular 
eosinophils
Glucocorticoids -oral prednisolone 40-60 
mg/day. 
In glucocorticoid failure/fulminant 
multisystem disease, the treatment of choice 
is a combined regimen of daily 
cyclophosphamide and prednisolone. 
Prognosis- 
 Without t/t-25% 
 With t/t-72%
Multisystem, necrotizing vasculitis of small 
and medium sized muscular arteries. 
Renal and visceral arteries are 
characteristically involved. 
Uncommon.
Necrotizing inflammation of small and 
medium sized muscular arteries. 
Lesions are segmental and involve bifurcation 
and branching of arteries. 
Aneurysmal dilatation of upto 1cm along 
involved arteries is characteristic. 
Pulmonary arteries are not involved; bronchial 
artery involvement is uncommon.
Kidney- arteritis without glomerulonephritis. 
It may be associated with Hepatitis B.
Non-specific- fever, malaise, weight loss. 
Renal (60%)- renal failure, hypertension. 
Musculoskeletal (64%)- arthritis, arthralgia, 
myalgia. 
Peripheral nervous system (51%)-peripheral 
neuropathy, mononeuritis multiplex. 
GI (44%)-abd pain, nausea, vomiting. 
Skin (43%)-livedo reticularis, rash, purpura, 
raynaud’s phenomena.
microaneurysms in the hepatic 
circulation. 
Livido reticularis
Lab findings- 
• Leukocyte counts is raised with neutrophil 
predominance. 
• Raised ESR 
• Anaemia of chronic disease. 
• Hypergammaglobulinemia. 
• All patients must be screened for Hep B.
Severe Cases-Prednisolone + 
Cyclophosphamide 
Less Severe- Prednisolone alone. 
Patient with Hepatitis B- Antiviral therapy 
with glucocorticoids and plasma exchange. 
Prognosis-o 
Without t/t-5 year survival rate is 10-20%. 
o Death is mainly b/s of GI complications and 
cardiovascular causes.
Cranial arteritis or temporal arteritis. 
Inflammation of medium and large sized 
arteries. 
Characteristically involves one or more 
branches of carotid artery-temporal artery.
It is closely assoc with polymyalgia 
rheumatica which is characterized by 
stiffness, aching and pain in muscle of neck, 
shoulder, lower back, hips and thigh. 
Occurs in >50 years of age. 
F>M 
Has association with HLA-DR4.
Histopathologically- panarteritis with 
inflammatory mononuclear cell infiltrate with 
giant cell formation. 
Antigen driven disease-activated T-lymphocytes, 
macrophages and dendritic 
cells.
Fever, anemia, high ESR and headache. 
Malaise, fatigue, anorexia, weight loss, 
sweats, arthralgia, polymyalgia rheumatica. 
Headache with tender thickened and nodular 
artery.
Scalp pain, claudication of jaw and tongue. 
Ischemic optic neuropathy- most feared 
complication. 
Stroke, scalp or tongue infarction. 
Arm claudication, aortic aneurysm. 
Lab Findings- 
• Raised ESR. 
• Normochromic or slightly hypochromic anemia. 
• Increased levels of IgG and complements.
Confirmed by biopsy of temporal artery. 
Segmental involvement-biopsy of 3-5 cm 
together with serial sectioning of biopsy 
specimen. 
Large vessel disease- suggested by physical 
examination and confirmed by vascular 
imaging.
Glucocorticoids- Prednisone 40-60 mg/d for 
1 month f/b gradual tapering. 
Ocular involvement-methylprednisolone 
1000 mg/d for 3 days. 
Treatment required for >2 years. 
Aspirin 81 mg/d-reduce cranial ischemic 
complication. 
Patient with isolated polymyalgia rheumatica-prednisone 
at lower dose. 
ESR- for monitoring of therapy.
Inflammatory and stenotic lesion of medium 
and large sized arteries. 
It has strong predilection for aortic arch and 
its branches. 
Incidence- 1.2-2.6 cases/million. 
Adolescent girls and young women.
Medium and large arteries. 
Panarteritis with inflammatory mononuclear 
cell infiltrate. 
Immunopathogenic mechanism.
Malaise, fever, night sweats, arthralgia, anorexia 
and weight loss. 
Subclavian (93%)- arm claudication, raynaud’s 
phenomena 
Common carotid (58%)- syncope, TIA, stroke. 
Abdominal aorta (47%)- abdominal pain, 
nausea,vomiting. 
Renal (38%)- hypertension, renal failure.
Lab findings- 
 Elevated ESR 
 Mild anemia 
 Elevated immunoglobulin levels.
Suspect in young women with decreased or 
absent peripheral pulses, discrepencies in BP 
with arterial bruits. 
Diagnosis confirmed by- arteriography which 
shows– irregular vessel wall, stenosis, post 
stenotic dilatation, aneurysm formation, 
occlusion with increased collateral circulation.
Arteriogram demonstrating 
stenosis of the abdominal 
Aorta. 
Arteriogram of the aortic arch 
demonstrating complete 
occlusion of the left common carotid 
artery just after its origin 
from the aorta.
Chronic and relapsing course. 
Prednisone 40-60 mg/d alleviates symptoms. 
Glucocorticoids therapy with surgical or 
arterioplastic approach– improved outcome. 
Refractory to glucocorticoid- methotrexate 
25mg/week. 
Mortality- CHF, MI, CVA, aneurysmal rupture or 
renal failure.
Also k/a anaphylactoid purpura. 
Small vessel vasculitis. 
Palpable purpura, arthralgias, GI signs and 
symptoms and glomerulonephritis. 
Children-4-7 years. 
Common. 
M:F- 1.5:1 
Peak incidence in spring.
Immune complex deposition. 
Inciting antigens- URTI, drugs, foods, insect 
bites, immunizations. 
IgA antibody-M/C seen.
Palpable purpura 
Polyarthralgia 
Colicky abdominal pain with nausea, vomting, 
diarrhoea or constipation accompanied by 
passage of blood and mucus per rectum. 
Bowel intussusception. 
Renal (10-50%)- mild glomerulonephritis-proteinuria 
and microscopic hematuria with 
rbc cast.
Lab studies- 
 mild leukocytosis, normal platelet count 
 Skin biopsy- leukocytoclastic vasculitis with 
IgA and C3 deposition.
Prednisone 1mg/kg/d-useful in decreasing 
tissue oedema, arthralgias and abdominal 
discomfort. 
Rapidly progressive glomerulonephritis-intensive 
plasma exchange with cytotoxic 
drugs. 
Prognosis- excellent.
Cryoglbulins are cold precipitable monoclonal 
or polyclonal immunoglobulins 
Idiopathic or associated with disorders like 
multiple myeloma, lymphoproliferative 
disorder, connective tissue diseases, 
infections and liver diseases. 
Hepatitis C is commonly related with it.
Skin biopsy- inflammatory infiltrate 
surrounding and involving blood vessel walls 
with fibrinoid necrosis, endothelial cell 
hyperplasia and haemorrhage. 
Membranoproliferative glomerulonephritis is 
responsible for 80% of all renal lesions.
Cutaneous vasculitis, arthritis, peripheral 
neuropathy and glomerulonephritis. 
Renal disease- 10-30%. 
Lab Findings- 
 Raised ESR 
 Anemia 
 Circulating cryoprecipitates 
 Rheumatoid factor-always found 
 Hypocomplementemia- 90%. 
 Hepatitis C screening.
Glomerulonephritis- poor prognostic sign 
15% end stage renal disease. 
Hepatitis C infection- IFN-α and ribavarin. 
Glucocorticoids- transient response. 
Plasmapheresis, cytotoxic agents- carry 
significant risk.
Also called as Primary angitis of CNS. 
vasculitis restricted to vessels of CNS without 
other systemic vasculitis. 
Mononuclear cell infiltrate with or without 
granuloma formation. 
Headache, altered mental function and focal 
neurological deficit. 
Systemic symptoms are absent.
Diagnosis- 
MRI Brain. 
Arteriography 
Cerebral arteriogram demonstrating 
beading alongbranches of the internal 
carotid artery
 Confirmed by biopsy of brain parenchyma 
and leptomeninges. 
Poor prognosis 
 Treatment-glucocorticoid 
± cyclophosphamide.
Lab features C/F 
WEGNER’S 
GRANULOMATOSIS 
Constitutional 
symptoms 
PNS pain,bloody nasal 
discharge,septal perforation 
Cough,haemoptysis 
M=F 
Age-40 yr 
Proteinuria,haematuria, 
RBC cast 
Conjuctivitis,dacrocystitis 
Palpable purpura,papules,vescile 
Mononeuritis multiplex 
anaemia 
Raised ESR 
leukocytosis 
cANCA+ve90% 
hypergammag 
lobulinemia 
Diagnosis-necrotizing 
granulomatous vasculitis 
on tissue biopsy 
Treatment 
cyclophosphamide+ 
glucocorticoid
1. Unexplained signs and symptoms 
2. Multisystem involvement 
3. Unexplained elevated ESR/CRP 
4. Skin lesions (palpable purpura) 
5. Ischemic vascular changes (Raynaud’s, 
gangrene, livedo, claudication) 
6. Glomerulonephritis 
7. Mononeuritis multiplex 
8. Inflammatory ocular disease 
9. Arthralgia's/arthritis, myalgia's 
10. Sudden visual loss/headache
Vasculits syndrome
Vasculits syndrome
Vasculits syndrome

Más contenido relacionado

La actualidad más candente

Antiphospholipid antibody syndrome
Antiphospholipid antibody syndromeAntiphospholipid antibody syndrome
Antiphospholipid antibody syndrome
Praveen Nagula
 
meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)
student
 

La actualidad más candente (20)

Vasculitis
VasculitisVasculitis
Vasculitis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
leukemoid reaction and leukemia
leukemoid reaction and leukemialeukemoid reaction and leukemia
leukemoid reaction and leukemia
 
Ascitic fluid analysis
Ascitic fluid analysis Ascitic fluid analysis
Ascitic fluid analysis
 
Non alcoholic steatohepatitis copy
Non alcoholic steatohepatitis   copyNon alcoholic steatohepatitis   copy
Non alcoholic steatohepatitis copy
 
Vasculitis pathology
Vasculitis pathologyVasculitis pathology
Vasculitis pathology
 
Giant Cell Arteritis
Giant Cell ArteritisGiant Cell Arteritis
Giant Cell Arteritis
 
Acute Coronary Syndrome - Overview
Acute Coronary Syndrome - OverviewAcute Coronary Syndrome - Overview
Acute Coronary Syndrome - Overview
 
Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
IgA nephropathy
IgA nephropathyIgA nephropathy
IgA nephropathy
 
Antiphospholipid antibody syndrome
Antiphospholipid antibody syndromeAntiphospholipid antibody syndrome
Antiphospholipid antibody syndrome
 
Cutaneous Vasculitis
Cutaneous VasculitisCutaneous Vasculitis
Cutaneous Vasculitis
 
Takayasu arteritis
Takayasu arteritisTakayasu arteritis
Takayasu arteritis
 
Mixed connective tissue disorder
Mixed connective tissue disorderMixed connective tissue disorder
Mixed connective tissue disorder
 
Thrombophilia
ThrombophiliaThrombophilia
Thrombophilia
 
Erythema nodosum
Erythema nodosumErythema nodosum
Erythema nodosum
 
meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)
 
Acute viral myocarditis
Acute viral  myocarditisAcute viral  myocarditis
Acute viral myocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
L4.approach to chest pain
L4.approach to chest painL4.approach to chest pain
L4.approach to chest pain
 

Destacado

Vasculitis syndromes
Vasculitis syndromesVasculitis syndromes
Vasculitis syndromes
Sarath Menon
 
Sensory manifestations of systemic diseases
Sensory manifestations of systemic diseasesSensory manifestations of systemic diseases
Sensory manifestations of systemic diseases
Ahmed Abdelraheem
 
Peripheral Neuropathies
Peripheral NeuropathiesPeripheral Neuropathies
Peripheral Neuropathies
mohammed sediq
 
Vasculitis Overview
Vasculitis OverviewVasculitis Overview
Vasculitis Overview
jcm MD
 

Destacado (20)

Manifestations of vasculitides and pseudovasculitides
Manifestations of vasculitides and pseudovasculitidesManifestations of vasculitides and pseudovasculitides
Manifestations of vasculitides and pseudovasculitides
 
Tutorial vasculitis
Tutorial vasculitisTutorial vasculitis
Tutorial vasculitis
 
Vasculitis syndromes
Vasculitis syndromesVasculitis syndromes
Vasculitis syndromes
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
везикулобуллезный паттерн
везикулобуллезный паттернвезикулобуллезный паттерн
везикулобуллезный паттерн
 
панникулитный паттерн
панникулитный паттернпанникулитный паттерн
панникулитный паттерн
 
иммунофлюоресцентные исследования при кожных болезнях
иммунофлюоресцентные исследования при кожных болезняхиммунофлюоресцентные исследования при кожных болезнях
иммунофлюоресцентные исследования при кожных болезнях
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
vasculitis
vasculitis vasculitis
vasculitis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Sensory manifestations of systemic diseases
Sensory manifestations of systemic diseasesSensory manifestations of systemic diseases
Sensory manifestations of systemic diseases
 
Churg Strauss Syndrome
Churg Strauss SyndromeChurg Strauss Syndrome
Churg Strauss Syndrome
 
Neurosarcoidosis
NeurosarcoidosisNeurosarcoidosis
Neurosarcoidosis
 
Vasculitis 2015
Vasculitis 2015Vasculitis 2015
Vasculitis 2015
 
Churg strauss syndrome
Churg strauss syndromeChurg strauss syndrome
Churg strauss syndrome
 
Anupa mishra
Anupa mishraAnupa mishra
Anupa mishra
 
Peripheral Neuropathies
Peripheral NeuropathiesPeripheral Neuropathies
Peripheral Neuropathies
 
Vasculitis Overview
Vasculitis OverviewVasculitis Overview
Vasculitis Overview
 
Vasculitis
Vasculitis Vasculitis
Vasculitis
 
Localization In Clinical Neurology
Localization In Clinical NeurologyLocalization In Clinical Neurology
Localization In Clinical Neurology
 

Similar a Vasculits syndrome

Coverted PPT
Coverted PPTCoverted PPT
Coverted PPT
Adil
 
33 ellabban care of the kidney during daily
33 ellabban   care of the kidney during daily33 ellabban   care of the kidney during daily
33 ellabban care of the kidney during daily
Dang Thanh Tuan
 
Granulomatosis de wegener
Granulomatosis de wegenerGranulomatosis de wegener
Granulomatosis de wegener
MINSA
 

Similar a Vasculits syndrome (20)

D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptxD. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
 
Secondary glomerular disorders.pptx
Secondary glomerular disorders.pptxSecondary glomerular disorders.pptx
Secondary glomerular disorders.pptx
 
Vasculitis 2013
Vasculitis 2013Vasculitis 2013
Vasculitis 2013
 
Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...
Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...
Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...
 
Coverted PPT
Coverted PPTCoverted PPT
Coverted PPT
 
Vasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBMVasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBM
 
Dermatology(saculitis)
Dermatology(saculitis)Dermatology(saculitis)
Dermatology(saculitis)
 
33 ellabban care of the kidney during daily
33 ellabban   care of the kidney during daily33 ellabban   care of the kidney during daily
33 ellabban care of the kidney during daily
 
1.primary glomerular diseases
1.primary glomerular diseases1.primary glomerular diseases
1.primary glomerular diseases
 
Nephrotic Syndrome.pptx
Nephrotic Syndrome.pptxNephrotic Syndrome.pptx
Nephrotic Syndrome.pptx
 
Pulmonary vasculitis
Pulmonary vasculitisPulmonary vasculitis
Pulmonary vasculitis
 
Granulomatosis de wegener
Granulomatosis de wegenerGranulomatosis de wegener
Granulomatosis de wegener
 
neurologic presentations of systemic vasculitis
neurologic presentations of systemic vasculitisneurologic presentations of systemic vasculitis
neurologic presentations of systemic vasculitis
 
Small vessel vasculitis
Small vessel vasculitisSmall vessel vasculitis
Small vessel vasculitis
 
VASCULITIS- CASE PRESENTATION
VASCULITIS- CASE PRESENTATION VASCULITIS- CASE PRESENTATION
VASCULITIS- CASE PRESENTATION
 
NEPHRITIC SYNDROME. Clinical Manifestations
NEPHRITIC SYNDROME. Clinical ManifestationsNEPHRITIC SYNDROME. Clinical Manifestations
NEPHRITIC SYNDROME. Clinical Manifestations
 
Mixed connective tissue disorder
Mixed connective tissue disorderMixed connective tissue disorder
Mixed connective tissue disorder
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Vaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritisVaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritis
 
vasculitis syndromes in rheumatology.pptx
vasculitis syndromes in rheumatology.pptxvasculitis syndromes in rheumatology.pptx
vasculitis syndromes in rheumatology.pptx
 

Más de Rahul Arya

Más de Rahul Arya (19)

Hypothyroidism
HypothyroidismHypothyroidism
Hypothyroidism
 
Hyperthyroidism
HyperthyroidismHyperthyroidism
Hyperthyroidism
 
Mitral stenosis
Mitral stenosisMitral stenosis
Mitral stenosis
 
Lung abscess
Lung abscessLung abscess
Lung abscess
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Iron deficiency anemia
Iron deficiency anemiaIron deficiency anemia
Iron deficiency anemia
 
Bronchiectasis
BronchiectasisBronchiectasis
Bronchiectasis
 
Thalassemia syndrome
Thalassemia syndromeThalassemia syndrome
Thalassemia syndrome
 
Approach to a case of anemia
Approach to a case of anemiaApproach to a case of anemia
Approach to a case of anemia
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Approach to a case of pain abdomen
Approach to a case of pain abdomenApproach to a case of pain abdomen
Approach to a case of pain abdomen
 
Diseases of adrenal cortex and medulla
Diseases of adrenal cortex and medullaDiseases of adrenal cortex and medulla
Diseases of adrenal cortex and medulla
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 
Lysosomal storage disorders
Lysosomal storage disordersLysosomal storage disorders
Lysosomal storage disorders
 
Approach to a patient of neurological tuberculosis
Approach to a patient of neurological tuberculosisApproach to a patient of neurological tuberculosis
Approach to a patient of neurological tuberculosis
 
Syndrome of inappropriate antidiuretic hormone secretion
Syndrome of inappropriate antidiuretic hormone secretionSyndrome of inappropriate antidiuretic hormone secretion
Syndrome of inappropriate antidiuretic hormone secretion
 
catheter related blood stream infections-complete material
catheter related blood stream infections-complete materialcatheter related blood stream infections-complete material
catheter related blood stream infections-complete material
 

Vasculits syndrome

  • 2. Vasculitis is a clinicopathologic process characterized by inflammation and damage to blood vessels, leading to compromise of the vascular lumen resulting in ischemia of the tissues supplied by the involved vessels.
  • 3. Inflammatory destruction of blood vessels • Infiltration of vessel wall with inflammatory cells – Leukocytoclasis – Elastic membrane disruption • Fibrinoid necrosis of the vessel wall • Ischemia, occlusion, thrombosis • Aneurysm formation • Rupture, hemorrhage
  • 4.
  • 5. ANCA are antibodies directed against certain proteins in cytoplasmic granules of neutrophils and monocytes. Types-i. Cytoplasmic ANCA ii. Perinuclear ANCA
  • 6. Cytoplasmic ANCA ◦ Stains cytoplasm (hence “c”) ◦ Main target antigen: proteinase-3 ◦ Associated with wegner’s granulomatosis (Granulomatosis with Polyangitis). Perinuclear ANCA ◦ Stains perinuclear (hence “p”) ◦ Main target antigen: myeloperoxidase ◦ Associated with churg strauss and microscopic polyangitis.
  • 7.
  • 8.
  • 9. Granulomatous vasculitis of upper and lower respiratory tracts with glomerulonephritis. Mean age of onset-40 years M:F= 1:1. Histopathological hallmark-necrotizing vasculitis of small arteries and veins with granuloma formation.
  • 10. Lung-multiple, bilateral,nodular, cavitary infiltrate Renal-focal,segmental glomerulitis that evolve into rapidly progressive crescentic glomerulnephritis
  • 11. Upper airway (95%)-PNS pain, purulent/bloody nasal discharge,nasal septal perforation (saddle nose). Pulmonary (85-90%)-cough, haemoptysis, dyspnea, chest discomfort. Renal (77%)-proteinuria, hematuria, RBC cast. Eye (52%) conjuctivitis, dacrocystitis, episcleritis, scleritis , ciliary vessel vasculitis, retroorbital mass lesion.
  • 12. Skin (46%)-papules, vesicles, palpable purpura, ulcer or s/c nodules. Nervous system (23%)- cranial neuritis, mononeuritis multiplex, cerebral vasculitis. Cardiac (8%)- pericarditis,coronary vasculitis, cardiomyopathy. Nonspecific symptoms- malaise, weakness, arthralgia and weight loss.
  • 13. Laboratory finding-ESR is raised, mild anemia, leukocytosis, mild hypergammaglobulinemia, mildly elevated rheumatoid factor.
  • 14. Demonstration of necrotizing granulomatous vasculitis on tissue biopsy. Pulmonary tissue-highest diagnostic yield. Renal biopsy-paauci-immune glomerulonephritis. Antibodies to cANCA-present in 90% pt with active disease; without active disease sensitivity is 60-70%.
  • 15. Cyclophosphamide + Glucocorticoid- for induction of therapy in severe disease.  Prednisolone 1mg/kg/d for 1st month f/b gradual tapering on alternate day or daily schedule with discontinuation after 6-9 months.  Cyclophosphamide 2mg/kg/d orally for 3-6 months. Remission maintanence- • Methotrexate 0.3 mg/kg single weekly (max 15 mg/week) • Azathioprine 2mg/kg/d • Mycophenolate mofetil- 1000 mg bd Maintanence therapy given for min 2 years.
  • 16. On t/t with cyclophosphamide • marked improvement is seen in >90% patient; • complete remission in 75% patient; • 5 year patient survival is >80%.
  • 17. It is a systemic necrotizing vasculitis without immune globulin deposition (pauci-immune) that affects mainly small vessels. Glomerulonephritis and pulmonary capillaritis is common. No granuloma formation. Mean age of onset- 57 years. M>F
  • 18. Mainly involves capillaries,venules along with small and medium sized arteries. Paucity of immunoglobin deposition. Associated with ANCA.
  • 19. Onset may be gradual- fever, weight loss and musculoskelatal pain. Glomerulonephritis (79%)-can be rapidly progressive leading to renal failure. Alveolar haemorrhage (12%)- haemoptysis. Mononeuritis multiplex, GI tract and cutaneous vasculitis.
  • 20. Lab Findings- ESR- raised Anaemia Leukocytosis Thrombocytosis ANCA- present in 75% (antimyeloperoxida se antibodies)
  • 21. Based on histologic evidence of vasculitis or pauciimmune glomerulnephritis. Sensitivity and specificity of ANCA is not established.
  • 22. Cyclophosphamide with prednisolone. 5 year survival with t/t is 74%.
  • 23. Also referred to as allergic angiitis and granulomatosis. characterized by asthma, peripheral and tissue eosinophilia , extravascular granuloma formation, and vasculitis of multiple organ systems. Incidence-uncommon (1-3/million) Mean age- 48 years M:F- 1.2:1.
  • 24. Involves small and medium-sized muscular arteries, capillaries, veins, and venules. characteristic histopathologic feature-granulomatous reactions associated with infiltration of the tissues with eosinophils. Lung involvement is predominant.
  • 25. Nonspecific-Fever, malaise,anorexia, and weight loss. Pulmonary finding-M/C manifestation Severe asthmatic attacks with pulmonary infiltration. Mononeuritis multiplex-2nd most common manifestation. Allergic rhinitis and sinusitis-61% Heart disease-14% ;important cause of mortality (CHF or Heart attack).
  • 26. Skin lesions occur in 51% of patients and include purpura in addition to cutaneous and subcutaneous nodules. The renal disease is less common and generally less severe.
  • 28. The characteristic finding-eosinophilia. Evidence of inflammation-elevated ESR, fibrinogen, or α2-globulins 48% of patients have circulating ANCA that is usually antimyeloperoxidase(pANCA).
  • 29. Lanham’s criteria (all of the following) ◦ Asthma ◦ Peak eosinophilia >1.5 x 109 cells/L ◦ Systemic vasculitis, two or > extrapulmonary sites American College of Rheumatology (4 of the following in the setting of vasculitis) ◦ Asthma ◦ Peak eosinophilia >10% total WBC ◦ Peripheral neuropathy attributed to vasculitis ◦ Transient pulmonary infiltrates ◦ Paranasal sinus disease ◦ Biopsy showing blood vessels with extravasular eosinophils
  • 30. Glucocorticoids -oral prednisolone 40-60 mg/day. In glucocorticoid failure/fulminant multisystem disease, the treatment of choice is a combined regimen of daily cyclophosphamide and prednisolone. Prognosis-  Without t/t-25%  With t/t-72%
  • 31.
  • 32. Multisystem, necrotizing vasculitis of small and medium sized muscular arteries. Renal and visceral arteries are characteristically involved. Uncommon.
  • 33. Necrotizing inflammation of small and medium sized muscular arteries. Lesions are segmental and involve bifurcation and branching of arteries. Aneurysmal dilatation of upto 1cm along involved arteries is characteristic. Pulmonary arteries are not involved; bronchial artery involvement is uncommon.
  • 34. Kidney- arteritis without glomerulonephritis. It may be associated with Hepatitis B.
  • 35. Non-specific- fever, malaise, weight loss. Renal (60%)- renal failure, hypertension. Musculoskeletal (64%)- arthritis, arthralgia, myalgia. Peripheral nervous system (51%)-peripheral neuropathy, mononeuritis multiplex. GI (44%)-abd pain, nausea, vomiting. Skin (43%)-livedo reticularis, rash, purpura, raynaud’s phenomena.
  • 36. microaneurysms in the hepatic circulation. Livido reticularis
  • 37. Lab findings- • Leukocyte counts is raised with neutrophil predominance. • Raised ESR • Anaemia of chronic disease. • Hypergammaglobulinemia. • All patients must be screened for Hep B.
  • 38. Severe Cases-Prednisolone + Cyclophosphamide Less Severe- Prednisolone alone. Patient with Hepatitis B- Antiviral therapy with glucocorticoids and plasma exchange. Prognosis-o Without t/t-5 year survival rate is 10-20%. o Death is mainly b/s of GI complications and cardiovascular causes.
  • 39.
  • 40. Cranial arteritis or temporal arteritis. Inflammation of medium and large sized arteries. Characteristically involves one or more branches of carotid artery-temporal artery.
  • 41. It is closely assoc with polymyalgia rheumatica which is characterized by stiffness, aching and pain in muscle of neck, shoulder, lower back, hips and thigh. Occurs in >50 years of age. F>M Has association with HLA-DR4.
  • 42. Histopathologically- panarteritis with inflammatory mononuclear cell infiltrate with giant cell formation. Antigen driven disease-activated T-lymphocytes, macrophages and dendritic cells.
  • 43. Fever, anemia, high ESR and headache. Malaise, fatigue, anorexia, weight loss, sweats, arthralgia, polymyalgia rheumatica. Headache with tender thickened and nodular artery.
  • 44. Scalp pain, claudication of jaw and tongue. Ischemic optic neuropathy- most feared complication. Stroke, scalp or tongue infarction. Arm claudication, aortic aneurysm. Lab Findings- • Raised ESR. • Normochromic or slightly hypochromic anemia. • Increased levels of IgG and complements.
  • 45. Confirmed by biopsy of temporal artery. Segmental involvement-biopsy of 3-5 cm together with serial sectioning of biopsy specimen. Large vessel disease- suggested by physical examination and confirmed by vascular imaging.
  • 46. Glucocorticoids- Prednisone 40-60 mg/d for 1 month f/b gradual tapering. Ocular involvement-methylprednisolone 1000 mg/d for 3 days. Treatment required for >2 years. Aspirin 81 mg/d-reduce cranial ischemic complication. Patient with isolated polymyalgia rheumatica-prednisone at lower dose. ESR- for monitoring of therapy.
  • 47. Inflammatory and stenotic lesion of medium and large sized arteries. It has strong predilection for aortic arch and its branches. Incidence- 1.2-2.6 cases/million. Adolescent girls and young women.
  • 48. Medium and large arteries. Panarteritis with inflammatory mononuclear cell infiltrate. Immunopathogenic mechanism.
  • 49. Malaise, fever, night sweats, arthralgia, anorexia and weight loss. Subclavian (93%)- arm claudication, raynaud’s phenomena Common carotid (58%)- syncope, TIA, stroke. Abdominal aorta (47%)- abdominal pain, nausea,vomiting. Renal (38%)- hypertension, renal failure.
  • 50. Lab findings-  Elevated ESR  Mild anemia  Elevated immunoglobulin levels.
  • 51. Suspect in young women with decreased or absent peripheral pulses, discrepencies in BP with arterial bruits. Diagnosis confirmed by- arteriography which shows– irregular vessel wall, stenosis, post stenotic dilatation, aneurysm formation, occlusion with increased collateral circulation.
  • 52. Arteriogram demonstrating stenosis of the abdominal Aorta. Arteriogram of the aortic arch demonstrating complete occlusion of the left common carotid artery just after its origin from the aorta.
  • 53. Chronic and relapsing course. Prednisone 40-60 mg/d alleviates symptoms. Glucocorticoids therapy with surgical or arterioplastic approach– improved outcome. Refractory to glucocorticoid- methotrexate 25mg/week. Mortality- CHF, MI, CVA, aneurysmal rupture or renal failure.
  • 54.
  • 55. Also k/a anaphylactoid purpura. Small vessel vasculitis. Palpable purpura, arthralgias, GI signs and symptoms and glomerulonephritis. Children-4-7 years. Common. M:F- 1.5:1 Peak incidence in spring.
  • 56. Immune complex deposition. Inciting antigens- URTI, drugs, foods, insect bites, immunizations. IgA antibody-M/C seen.
  • 57. Palpable purpura Polyarthralgia Colicky abdominal pain with nausea, vomting, diarrhoea or constipation accompanied by passage of blood and mucus per rectum. Bowel intussusception. Renal (10-50%)- mild glomerulonephritis-proteinuria and microscopic hematuria with rbc cast.
  • 58.
  • 59. Lab studies-  mild leukocytosis, normal platelet count  Skin biopsy- leukocytoclastic vasculitis with IgA and C3 deposition.
  • 60. Prednisone 1mg/kg/d-useful in decreasing tissue oedema, arthralgias and abdominal discomfort. Rapidly progressive glomerulonephritis-intensive plasma exchange with cytotoxic drugs. Prognosis- excellent.
  • 61. Cryoglbulins are cold precipitable monoclonal or polyclonal immunoglobulins Idiopathic or associated with disorders like multiple myeloma, lymphoproliferative disorder, connective tissue diseases, infections and liver diseases. Hepatitis C is commonly related with it.
  • 62. Skin biopsy- inflammatory infiltrate surrounding and involving blood vessel walls with fibrinoid necrosis, endothelial cell hyperplasia and haemorrhage. Membranoproliferative glomerulonephritis is responsible for 80% of all renal lesions.
  • 63. Cutaneous vasculitis, arthritis, peripheral neuropathy and glomerulonephritis. Renal disease- 10-30%. Lab Findings-  Raised ESR  Anemia  Circulating cryoprecipitates  Rheumatoid factor-always found  Hypocomplementemia- 90%.  Hepatitis C screening.
  • 64. Glomerulonephritis- poor prognostic sign 15% end stage renal disease. Hepatitis C infection- IFN-α and ribavarin. Glucocorticoids- transient response. Plasmapheresis, cytotoxic agents- carry significant risk.
  • 65. Also called as Primary angitis of CNS. vasculitis restricted to vessels of CNS without other systemic vasculitis. Mononuclear cell infiltrate with or without granuloma formation. Headache, altered mental function and focal neurological deficit. Systemic symptoms are absent.
  • 66. Diagnosis- MRI Brain. Arteriography Cerebral arteriogram demonstrating beading alongbranches of the internal carotid artery
  • 67.  Confirmed by biopsy of brain parenchyma and leptomeninges. Poor prognosis  Treatment-glucocorticoid ± cyclophosphamide.
  • 68.
  • 69. Lab features C/F WEGNER’S GRANULOMATOSIS Constitutional symptoms PNS pain,bloody nasal discharge,septal perforation Cough,haemoptysis M=F Age-40 yr Proteinuria,haematuria, RBC cast Conjuctivitis,dacrocystitis Palpable purpura,papules,vescile Mononeuritis multiplex anaemia Raised ESR leukocytosis cANCA+ve90% hypergammag lobulinemia Diagnosis-necrotizing granulomatous vasculitis on tissue biopsy Treatment cyclophosphamide+ glucocorticoid
  • 70.
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76. 1. Unexplained signs and symptoms 2. Multisystem involvement 3. Unexplained elevated ESR/CRP 4. Skin lesions (palpable purpura) 5. Ischemic vascular changes (Raynaud’s, gangrene, livedo, claudication) 6. Glomerulonephritis 7. Mononeuritis multiplex 8. Inflammatory ocular disease 9. Arthralgia's/arthritis, myalgia's 10. Sudden visual loss/headache